Phio Pharmaceuticals Statistics

Total Valuation

PHIO has a market cap or net worth of $2.30 million. The enterprise value is -$4.18 million.

Market Cap	2.30M
Enterprise Value	-4.18M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, after market close.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

PHIO has 510,188 shares outstanding. The number of shares has increased by 300.98% in one year.

Shares Outstanding	510,188
Shares Change (YoY)	+300.98%
Shares Change (QoQ)	+119.82%
Owned by Insiders (%)	0.63%
Owned by Institutions (%)	3.94%
Float	506,322

Valuation Ratios

PE Ratio	n/a
Forward PE	0.31
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.41
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.48, with zero debt.

Current Ratio	5.48
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -123.20% and return on invested capital (ROIC) is -168.29%.

Return on Equity (ROE)	-123.20%
Return on Assets (ROA)	-98.60%
Return on Capital (ROIC)	-168.29%
Revenue Per Employee	n/a
Profits Per Employee	-$1.04M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.48% in the last 52 weeks. The beta is 1.45, so PHIO's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	-81.48%
50-Day Moving Average	6.26
200-Day Moving Average	7.70
Relative Strength Index (RSI)	34.30
Average Volume (20 Days)	22,733

Short Selling Information

The latest short interest is 142,456, so 27.92% of the outstanding shares have been sold short.

Short Interest	142,456
Short Previous Month	152,025
Short % of Shares Out	27.92%
Short % of Float	28.14%
Short Ratio (days to cover)	3.46

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.43M
Pretax Income	-9.38M
Net Income	-9.38M
EBITDA	-9.21M
EBIT	-9.38M
Earnings Per Share (EPS)	-$29.25

Full Income Statement

Balance Sheet

The company has $6.48 million in cash and no debt, giving a net cash position of $6.48 million or $12.69 per share.

Cash & Cash Equivalents	6.48M
Total Debt	n/a
Net Cash	6.48M
Net Cash Per Share	$12.69
Equity (Book Value)	5.60M
Book Value Per Share	10.98
Working Capital	5.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.05 million and capital expenditures -$5,000, giving a free cash flow of -$10.06 million.

Operating Cash Flow	-10.05M
Capital Expenditures	-5,000
Free Cash Flow	-10.06M
FCF Per Share	-$19.76

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PHIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-300.98%
Shareholder Yield	-300.98%
Earnings Yield	-408.48%
FCF Yield	-438.05%

Analyst Forecast

The average price target for PHIO is $36.00, which is 700.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$36.00
Price Target Difference	700.00%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 5, 2024. It was a reverse split with a ratio of 1:9.

Last Split Date	Jul 5, 2024
Split Type	Reverse
Split Ratio	1:9

Scores

Altman Z-Score	n/a
Piotroski F-Score	1